Paxil CR and Avandamet were taken off the market.
No. Paxil CR and Avandamet have NOT been taken off the market. There is some confusion however because on March 4th, U.S. marshals seized stocks of Paxil CR and Avandamet from several manufacturing sites of GlaxoSmith Kline. This has caused a widespread shortage of both Paxil CR and Avandamet.
The problem was that manufacturing problems resulted in flawed tablets and unreliable amounts of pharmaceutical ingredients.
There was concern that the Paxil CR tablets could split apart. This could potentially result in patients getting a portion of a tablet that may lack active ingredient or not have the controlled-release effect.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote